Cargando…
The dual role of CD6 as a therapeutic target in cancer and autoimmune disease
Autoimmune disease involves loss of tolerance to self-antigen, while progression of cancer reflects insufficient recognition and response of the immune system to malignant cells. Patients with immune compromised conditions tend to be more susceptible to cancer development. On the other hand, cancer...
Autores principales: | Gurrea-Rubio, Mikel, Fox, David A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9579686/ https://www.ncbi.nlm.nih.gov/pubmed/36275816 http://dx.doi.org/10.3389/fmed.2022.1026521 |
Ejemplares similares
-
CD6 is a target for cancer immunotherapy
por: Ruth, Jeffrey H., et al.
Publicado: (2021) -
New Therapeutic Targets in Autoimmune Cholangiopathies
por: Gerussi, Alessio, et al.
Publicado: (2020) -
Editorial: Pathological reactions of cytotoxic lymphoid cells as universal therapeutic targets in cancer and autoimmune disease
por: Sumbayev, Vadim V., et al.
Publicado: (2023) -
Therapeutic approaches targeting CD95L/CD95 signaling in cancer and autoimmune diseases
por: Risso, Vesna, et al.
Publicado: (2022) -
Rationale for Targeting CD6 as a Treatment for Autoimmune Diseases
por: Alonso-Ramirez, Ruby, et al.
Publicado: (2010)